发明名称 |
Vaccine for the Prevention of Breast Cancer Relapse |
摘要 |
The invention features methods to induce and maintain a protective cytotoxic T-lymphocyte response to a peptide of the HER2/neu oncogene, E75, with the effect of inducing and maintaining protective or therapeutic immunity against breast cancer in a patient in clinical remission. The methods comprise administering to the patient an effective amount of a vaccine composition comprising a pharmaceutically acceptable carrier, an adjuvant such as recombinant human GM CSF, and the E75 peptide at an optimized dose and schedule. The methods further comprise administering an annual or semi-annual booster vaccine dose due to declining E75-specific T cell immunity. The invention also features vaccine compositions for use in the methods. |
申请公布号 |
AU2014201488(B2) |
申请公布日期 |
2016.06.30 |
申请号 |
AU20140201488 |
申请日期 |
2014.03.13 |
申请人 |
THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. |
发明人 |
PEOPLES, GEORGE E.;SATHIBALAN, PONNIAH |
分类号 |
C07K16/00;A61K38/00;A61K39/00;A61K39/38;C07K17/00 |
主分类号 |
C07K16/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|